Unionview LLC’s Zoetis ZTS Stock Holding History

Unionview LLC’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,130	Closed	-$276K	–	99
2021 Q4	$276K	Buy	+1,130	New	+$248K	0.26%	69

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Unionview LLC's ZTS Position: Q1 2022 in Review

Unionview LLC sold out of Zoetis (ZTS) in Q1 2022, closing a stake of 1,130 shares — an estimated $276K sold.

Unionview LLC first reported a position in ZTS in Q4 2021 and held it in 1 quarter. The position peaked at $276K in Q4 2021. 1,638 funds tracked by Wall St. Rank hold ZTS as of Q1 2022.

Unionview LLC reported no remaining Zoetis position as of Q1 2022 after selling out during the quarter.
Unionview LLC sold 1,130 Zoetis shares in Q1 2022, an estimated $276K.
Unionview LLC first reported a position in Zoetis in Q4 2021 and held it in 1 quarter.
Unionview LLC's Zoetis position peaked at $276K in Q4 2021.
1,638 funds tracked by Wall St. Rank held Zoetis as of Q1 2022.

Based on Unionview LLC's 13F filing for Q1 2022, filed 16 May 2022.